Novartis (NVS) Enters $1.7 Billion Development Deal, Says Report
We recently published 13 Best ADR Stocks to Invest In. Novartis AG (NYSE:NVS) is one of the best…
Novartis Drops $1.7 Billion on AI Allergy Breakthrough
This article first appeared on GuruFocus. Novartis (NYSE:NVS) is doubling down on AI-driven drug discovery with a deal…